ScienceDex / Researcher record
Dipanjan Chowdhury
- UT Health Science Center Houston · Biochemistry (NIH department code)
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #1,397
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,431,574 | 4 | #9,309 |
| 2025 | $1,562,024 | 4 | #9,524 |
| 2026 | $7,659,036 | 5 | #1,397 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20254 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9389403Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-5645-3752Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Biochemistry
FY2026 award records by amount
NIH award records listing Dipanjan Chowdhury as a PI. Multi-PI records show the full award amount for context.
- 4R01CA284565-03R01Contact PIEnhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities$2.5Maward amount
- 5P01CA275717-03P01Contact PIRegulation of BRCA-dependent Genome Repair via the 53BP1 AxisUT Health Science Center Houston · Biochemistry (NIH department code)$2.5Maward amount
- 5U54CA274516-04U54Contact PIRadiation Oncology at the Interface of Pediatric Cancer Biology and Data Science$1.5Maward amount
- 1R01CA301574-01A1R01Co-investigatorTIRR/53BP1 complex regulates mitotic fidelity and immune-mediated radiation response$683.1Kaward amount
- 5R01CA264900-05R01Contact PIElucidating the molecular mechanism and physiological relevance of TIRR mediated inhibition of p53$387.8Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Dipanjan Chowdhury as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9309
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026$10M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #1397
- 2026Entered Top 10% NationallyRanked #1397
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Dipanjan Chowdhury.
Daphne A. Haas-Kogan
Dana-Farber Cancer Institute
6
shared awards
Alexander V Mazin
UT Health Science Center Houston
3
shared awards
David Kozono
Dana-Farber Cancer Institute
3
shared awards
David Steven Libich
UT Health Science Center Houston
3
shared awards
Franziska Michor
Dana-Farber Cancer Institute
3
shared awards
Patrick Sung
UT Health Science Center Houston
3
shared awards
Robert A Hromas
UT Health Science Center Houston
3
shared awards
Ross I. Berbeco
Dana-Farber Cancer Institute
3
shared awards
Sandeep Burma
UT Health Science Center Houston
3
shared awards
Youngho Kwon
UT Health Science Center Houston
3
shared awards